Skip to menu Skip to content Skip to footer

The Neurokinin 3 Receptor is a New Target for the Treatment of Autism Spectrum Disorder (2023-2027)

Experts

Dr Nathalie Dehorter

Senior Research Fellow
Queensland Brain Institute
Faculty of Health, Medicine and Behavioural Sciences
Nathalie Dehorter